Spyre Therapeutics Files 2024 10-K
Ticker: SYRE · Form: 10-K · Filed: Feb 27, 2025 · CIK: 1636282
| Field | Detail |
|---|---|
| Company | Spyre Therapeutics, Inc. (SYRE) |
| Form Type | 10-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, pharmaceuticals, financials
TL;DR
Spyre Therapeutics filed its 2024 10-K, detailing financials for the year ending Dec 31, 2024.
AI Summary
Spyre Therapeutics, Inc. filed its 2024 10-K on February 27, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The company, formerly known as Aeglea BioTherapeutics, Inc. until March 11, 2015, is focused on pharmaceutical preparations. Its principal executive offices are located in Waltham, MA.
Why It Matters
This filing provides a comprehensive overview of Spyre Therapeutics' financial health and operational status for the past fiscal year, crucial for investors and stakeholders to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — The provided text is a standard 10-K filing header and does not contain specific financial performance data or forward-looking statements that would indicate a high risk.
Key Players & Entities
- Spyre Therapeutics, Inc. (company) — Filer
- Aeglea BioTherapeutics, Inc. (company) — Former company name
- 2024-12-31 (date) — Fiscal year end
- 2025-02-27 (date) — Filing date
- Waltham, MA (location) — Business address
FAQ
What was Spyre Therapeutics' former name?
Spyre Therapeutics, Inc. was formerly known as Aeglea BioTherapeutics, Inc.
When did the company change its name?
The company changed its name on March 11, 2015.
What is Spyre Therapeutics' Standard Industrial Classification (SIC) code?
Spyre Therapeutics' SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Where is Spyre Therapeutics, Inc. located?
Spyre Therapeutics, Inc. is located at 221 Crescent Street, Building 23, Suite 105, Waltham, MA 02453.
On what date was the 10-K filing for the fiscal year ending December 31, 2024, submitted?
The 10-K filing was submitted on February 27, 2025.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 27, 2025 regarding Spyre Therapeutics, Inc. (SYRE).